FS

Florence Sejourne

Chief Executive Officer

AUROBAC THERAPEUTICS

Paris, Ile-de-France


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
AUROBAC THERAPEUTICS
Industry
biotechnology
Employees
29.0
Seniority
C suite

Technologies

Outlook Microsoft Office 365 Apache YouTube WordPress.org Mobile Friendly Remote AI

Keywords

biopharmaceutical antimicrobial resistance acute bacterial infections critical care hospital-acquired infections ventilator-associated pneumonia hospital-acquired pneumonia sepsis septic shock diagnostic strategies precision medicines innovative treatment patient stratification treatment optimization clinical trials emerging pathogens gram-negative bacteria multi-drug resistance antibiotic stewardship therapeutic development pathogen-targeted programs r&d pipeline biologics new chemical entities first-in-class drugs healthcare-associated infections diagnostic innovation medical needs clinical efficacy novel antibiotics synthetic peptides infection prevention drug discovery collaborative research healthcare economics patient outcomes acute respiratory infections life-threatening infections intensive care nosocomial infections economic burden clinical microbiology globally relevant pathogens biomedical research partnership opportunities drug development strategy preclinical studies infectious diseases bacterial pathogens health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans